|
|
|
|
U.S. Department of Agriculture,2 Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND 58202
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: copper deficiency Falling Disease ischemic heart disease
| INTRODUCTION |
|---|
|
|
|---|
"Falling Disease" was an enzootic disease of dairy cattle
characterized by seasonal incidence and sudden death (Bennetts and Hall 1939
). The disease constituted a "grave economic
problem." Some herds experienced an annual mortality of 540%.
Although sudden death had been reported in bulls, it was most
frequently observed when cows were being brought in to be milked or
were being driven out to paddock. Some cows had fallen on the milker
after a bellow and a toss of the
head.3
Death frequently appeared to be instantaneous. Although the authors
mentioned anemia, excessive and cloudy pericardial fluid, and low
copper status of both animals and pasture, the disease was said to be
of "undetermined ætiology." Although it "seemed very unlikely
that a mineral deficiency per se could be the cause of
sudden death," its contribution was suspected.
| Anatomy |
|---|
|
|
|---|
Later, Shields et al. (1962)
found numerous
cardiovascular lesions among 26 swine made deficient in Utah with a
diet based on evaporated milk. The most important cardiac lesions were
myocardial infarction and ruptured papillary muscles with intramural
hemorrhage. Vascular lesions included aortic fissures and rupture,
medial thickening of the aorta and intramural hemorrhages in carotid,
coronary and other thoracic arteries. They also found that copper
deficiency produced greater cardiac enlargement than iron deficiency
when animals were matched by hematocrit.
Although cardiac enlargement in copper deficiency was noted first by
Schultze (1939)
, he mentioned the phenomenon only
briefly. Kelly et al. (1974)
confirmed the enlargement
and also credited others (Dallman 1967
, Gubler et al. 1957
).
A short time later, Ball et al. (1963)
began to publish
changes in cardiovascular anatomy found in mice fed a diet high in lard
in Mississippi. Atrial thrombosis was most obvious, but coronary
necrosis, coronary thrombosis, myocardial necrosis and ventricular
calcification also were found. Mortality was high. Two decades later,
it was found that adequate dietary copper (Klevay 1985
)
could prevent the atrial lesions and eliminate premature mortality.
Copper was an antidote to fat intoxication.
Coulson and Carnes (1963)
noted that 22 of 33 pigs
deficient in copper died of cardiovascular causes, 11 with fatal
coronary artery disease. Continuation of this work revealed smooth
muscle proliferation (Carnes et al. 1965
), a finding
confirmed by Hunsaker et al. (1984)
and Hill and Davidson (1986)
. Hunsaker et al. (1984)
also
noted migration of smooth muscle cells in aortas of marginally
copper-deficient rats. Arterial foam cells also were found in
deficient swine (Waisman et al. 1969
).
Approximately 35 anatomical changes produced by copper deficiency have
been tabulated from the work of numerous authors (Klevay 2000
). Important findings in addition to those above are
arteries with elastic degeneration and fragmentation, arteries with
smooth muscle degeneration, along with ventricular and coronary artery
aneurysms.
| Chemistry |
|---|
|
|
|---|
All enzymes known to depend on copper for activity are oxidative
(Prohaska 1990
). Some of these enzymes are important for
cardiovascular health. Crosslinking of arterial collagen and elastin
requires lysyl oxidase, a copper enzyme (Owen 1982
).
Arterial proteoglycan metabolism also is disrupted by copper deficiency
(Radhakrishnamurthy et al. 1989
).
Copper-zinc superoxide dismutase is found in various tissues, is
dependent on copper for activity (Owen 1982
) and is
protective against free radicals (McCord 1985
,
Southorn and Powis 1988
). It has been suggested that
copper is an antioxidant nutrient for cardiovascular health
(Allen and Klevay 1994
, Klevay 1990a
).
Malondialdehyde and thiobarbituric acid reactive substances are indices
of peroxidation that are increased in the serum in coronary artery
disease and angina pectoris (Mendis et al. 1995
,
Sakuma et al. 1997
) and in plasma of
copper-deficient rats (Klevay 2000
, Saari et al. 1990
). Russo et al. (1998)
found lower
plasma copper and lower erythrocyte superoxide dismutase activity and
higher malondialdehyde in people with newly diagnosed essential
hypertension compared with normotensive people matched for age.
Dubick et al. (1999)
found that copper, zinc superoxide
dismutase activity in aortas of people with abdominal aneurysms was
decreased by more than two thirds.
Cholesterol metabolism and copper utilization were linked when a high
ratio of zinc to copper ingested produced hypercholesterolemia in rats
(Klevay 1973
and 1987b
). A similar phenomenon was
observed first in people by Hooper et al. (1980)
who
found dislipidemia in men with zinc supplements. Human
hypercholesterolemia from a diet of conventional foods low in copper
was observed first in a 29-y-old man (Klevay et al. 1984
). Hypercholesterolemia from copper deficiency in several
species has been found in at least 22 independent laboratories
world-wide (Klevay 2000
).
| Physiology |
|---|
|
|
|---|
Rats depleted of copper after they reach adult size become hypertensive
(Klevay 1987a
, Medeiros 1987
), perhaps
from impaired vasodilation in response to acetylcholine (Saari 1992
). Women fed diets of conventional foods low in copper had
increased blood pressure during sustained handgrip (Lukaski et al. 1988
).
| Thoughts from the 1990s |
|---|
|
|
|---|
Bennetts et al. (1942)
assumed that the ultimate cause
of sudden death in copper deficiency was either ventricular
fibrillation or heart block. To my knowledge, fibrillation has not been
recorded in copper deficiency, perhaps because most recordings have
been on rats, which are small animals with small hearts that are
resistant to fibrillation, and perhaps because fibrillation causes
rapid death. Electrocardiograms were recorded in a multiyear study of
bovine copper deficiency; "quite extensive fibroic lesions may occur
without any abnormality being detected ... within a few weeks of
death" (Bennetts et al. 1948
). They also alluded to
involvement of the conduction system (Bennetts et al. 1948
). In view of their dependence on "two Perth medical
practitioners," subtle effects may have been overlooked because of an
apparent lack of recordings on supplemented cows and possible subtle,
species differences in cardiograms. It seems likely that early bovine
electrocardiography was not very good because human electrocardiography
has improved greatly in a half century. I experienced some initial
difficulty sorting rat cardiograms into groups to identify
abnormalities from copper deficiency.
One may wonder why hypercholesterolemia and abnormal electrocardiograms
of copper deficiency were not discovered much earlier, considering the
numerous experiments that have been done since 1928. Altered lipid
metabolism might have been noticed if triglyceridemia had been much
greater. Hypercholesterolemic plasma is more or less transparent; only
hypertriglyceridemia can produce plasma that looks like cream. Most of
the earlier students of copper deficiency were preoccupied by
hematology. In contrast, I was looking for effects of trace elements on
cholesterol (Klevay 1977
and 1987b
), although I was not
particularly interested in copper deficiency after completing a thesis
on bile acids and dietary fat. By the time we had 13 of 15 deficient
rats die suddenly over the course of several days (Allen and Klevay,
unpublished), we were ready to record cardiograms having been inspired
by Paul D. Whites cardiograms on whales. We had seen some pretty bad
looking hearts in deficient rats (Allen and Klevay 1978
,
Kopp et al. 1983
, Viestenz and Klevay 1982
) and had assumed that their function was poor.
Bennetts et al. (1942)
were the first to note the
similarity of cardiac fibrosis in "Falling Disease" to that in
humans after arteriosclerosis. In contrast Carnes et al. (1965)
denied the likelihood that copper deficiency had any
bearing on human atherosclerosis (Klevay 1990b
).
However, smooth muscle proliferation (Carnes et al. 1965
, Hill and Davidson 1986
, Hunsaker et al. 1984
), migration (Hunsaker et al. 1984
) and
arterial foam cells (Waisman et al. 1969
) are important
in the early stages of the atherosclerotic process in humans
(Klevay 1990b
). Decades passed before the next
suggestion that copper deficiency could be important in human heart
disease (Anderson et al. 1975
, Klevay 1973
and 1990b
).
Low cardiac copper in ischemic heart disease, better coronary arteries
in men with higher white blood cell copper, higher copper in Japanese
leukocytes in Okinawa, decreased lysyloxidase in human hypertension and
decreased superoxide dismutase with myocardial infarction are consonant
with the concept that copper nutriture of people with ischemic heart
disease is poor. The data on superoxide dismutase are consonant with
the suggestions (Klevay 1996
, Tilson 1982
) that abnormalities of copper utilization contribute to
the formation of aneurysms. Because the cardiac enlargement
(Dallman 1967
) and abnormal cardiograms (Viestenz and Klevay 1982
) of copper deficiency are reversible with the
treatment of deficiency, one wonders about the possibility of copper
treatment in these seemingly low copper states. It is interesting that
abnormal electrocardiograms (Klevay et al. 1985
),
abnormal cardiac histology (Klevay et al. 1994
) and
abnormal arterial structure (Hunsaker et al. 1984
) have
been found in animals mildly deficient in copper without obvious
alteration in peripheral, copper chemistry.
It seems clear that people respond to diets low in copper similarly to
several species of animals. To date, >100 men and women have resembled
animals in their responses to diets low in copper or to zinc
supplements (Klevay 1990b
and 1998
). The low copper
diets contained amounts of copper similar to those readily available to
the U.S. population; some of the doses of zinc supplements do not
exceed the RDA by very much (Klevay 1998
). More than 75
anatomical, chemical and physiologic changes are common to both animals
deficient in copper and people with ischemic heart disease.
The copper deficiency theory on the etiology and pathophysiology of
ischemic heart disease has been developed in a series of papers over
two decades; the most important or recent include Klevay 1990a
, 1990b
, 1998
and 2000
). The theory has evolved, has been
modified and has attempted to incorporate newer concepts and findings
such as aspirin, beer, homocysteine, iron overload and oxidative
damage. It is offered as the simplest and most general explanation of
ischemic heart disease, the leading cause of death in the
industrialized world.
| FOOTNOTES |
|---|
2 The U.S. Department of Agriculture, Agricultural Research Service, Northern Plains Area, is an equal opportunity/affirmative action employer and all agency services are available without discrimination.
3 Prof. George K. Davis witnessed similar events early in his work on "Quick Death" in the Florida Everglades. Copper deficiency in cattle often is secondary to excessive dietary molybdenum.
| REFERENCES |
|---|
|
|
|---|
1. Allen K. G., Klevay L. M. Cholesterolemia and cardiovascular abnormalities in rats caused by copper deficiency. Atherosclerosis 1978;29:81-93[Medline]
2. Allen K. G., Klevay L. M. Copper: an antioxidant nutrient for cardiovascular health. Curr. Opin. Lipidol. 1994;5:22-28[Medline]
3. Anderson T. W., Neri L. C., Schreiber G. B., Talbot F. D., Zdrojewski A. Ischemic heart disease, water hardness and myocardial magnesium. Can. Med. Assoc. J. 1975;113:199-203[Abstract]
4. Ball C. R., Williams W. L., Collum J. M. Cardiovascular lesions in Swiss mice fed a high fat-low protein diet with and without betaine supplementation. Anat. Rec. 1963;145:49-59[Medline]
5. Bennetts H. W., Beck A. B., Harley R. The pathogenesis of "Falling Disease." Studies on copper deficiency in cattle. Aust. Vet. J. 1948;24:237-244
6. Bennetts H. W., Hall H. T. "Falling Disease" of cattle in the south-west of western Australia. Aust. Vet. J. 1939;15:152-159
7. Bennetts H. W., Harley R., Evans S. T. Studies on copper deficiency of cattle: the fatal termination ("Falling Disease"). Aust. Vet. J. 1942;18:50-63
8. Bergomi M., Rovesti S., Vinceti M., Vivoli R., Caselgrandi E., Vivoli G. Zinc and copper status and blood pressure. J. Trace Elem. Med. Biol. 1997;11:166-169[Medline]
9. Carnes W. H., Coulson W. F., Albino A. M. Intimal lesions in muscular arteries of young copper-deficient swine. Ann. N. Y. Acad. Sci. 1965;127:800-810[Medline]
10. Chipperfield B., Chipperfield J. R. Differences in metal content of the heart muscle in death from ischemic heart disease. Am. Heart J. 1978;95:732-737[Medline]
11. Coulson W. F., Carnes W. H. Cardiovascular studies on copper-deficient swine V. The histogenesis of the coronary artery lesions. Am. J. Pathol. 1963;43:945-954[Medline]
12. Dallman P. R. Cytochrome oxidase repair during treatment of copper deficiency: relation to mitochondrial turnover. J. Clin. Invest. 1967;46:1819-1827
13. Dubick M. A., Keen C. L., DiSilvestro R. A., Eskelson C. D., Ireton J., Hunter G. C. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc. Soc. Exp. Biol. Med. 1999;220:39-45[Medline]
14.
Gallagher C. H., Judah J. D., Rees K. R. The biochemistry of copper deficiency I. Enzymological disturbances, blood chemistry and excretion of amino-acids. Proc. R. Soc. Lond. [B] 1956;145:134-150
15.
Gubler C. J., Cartwright G. E., Wintrobe M. M. Studies on copper metabolism XX. Enzyme activities and iron metabolism in copper and iron deficiencies. J. Biol. Chem. 1957;224:533-546
16.
Hart E. B., Steenbock H., Waddell J., Elvehjem C. A. Iron in nutrition. VII. Copper as a supplement to iron for hemoglobin building in the rat. J. Biol. Chem. 1928;77:797-812
17.
Hill K. E., Davidson J. M. Induction of increased collagen and elastin biosynthesis in copper-deficient pig aorta. Arteriosclerosis 1986;6:98-104
18.
Hooper P. L., Visconti L., Garry P. J., Johnson G. E. Zinc lowers high-density lipoprotein-cholesterol levels. JAMA 1980;244:1960-1961
19. Hunsaker H. A., Morita M., Allen K. G. Marginal copper deficiency in rats. Aortal morphology of elastin and cholesterol values in first-generation adult males. Atherosclerosis 1984;51:1-19[Medline]
20. Kelly W. A., Kesterson J. W., Carlton W. W. Myocardial lesions in the offspring of female rats fed a copper deficient diet. Exp. Mol. Pathol. 1974;20:40-56[Medline]
21.
Keil H. L., Nelson V. E. The rôle of copper in carbohydrate metabolism. J. Biol. Chem. 1934;106:343-349
22. Kinsman G. D., Howard A. N., Stone D. L., Mullins P. A. Studies in copper status and atherosclerosis. Biochem. Soc. Trans. 1990;18:1186-1188[Medline]
23. Klevay L. M. Hypercholesterolemia in rats produced by an increase in the ratio of zinc to copper ingested. Am. J. Clin. Nutr. 1973;26:1060-1068[Abstract]
24. Klevay L. M. Elements of ischemic heart disease. Perspect. Biol. Med. 1977;20:186-192[Medline]
25. Klevay L. M. Atrial thrombosis, abnormal electrocardiograms and sudden death in mice due to copper deficiency. Atherosclerosis 1985;54:213-224[Medline]
26. Klevay L. M. Hypertension in rats due to copper deficiency. Nutr. Rep. Int. 1987a;35:999-1005
27. Klevay, L. M. (1987b) This weeks citation classic on hypercholesterolemia in rats produced by an increase in the ratio of zinc to copper ingested. Am. J. Clin. Nutr. 26: 10601068. Current Contents Clin. Med. 15: 2022.
28. Klevay L. M. Ischemic heart disease as copper deficiency. Kies C. eds. Copper Bioavailability and Metabolism (Adv. Exp. Med. Biol., vol. 258) 1990a:197-208 Plenum Press New York, NY.
29. Klevay L. M. Ischemic heart disease: toward a unified theory. Lei K. Y. Carr T. P. eds. Role of Copper in Lipid Metabolism/TITLE> 1990b:233-267 CRC Press Boca Raton, FL.
30. Klevay L. M. Trace elements, atherosclerosis, and abdominal aneurysms. Ann. N. Y. Acad. Sci. 1996;800:239-242[Medline]
31. Klevay L. M. Copper as a supplement to iron for hemoglobin building in the rat (Hart et al., 1928). J. Nutr. 1997;127:1034S-1036S
32.
Klevay L. M. Lack of a recommended dietary allowance for copper may be hazardous to your health. J. Am. Coll. Nutr. 1998;17:322-326
33. Klevay L. M. Trace element and mineral nutrition in disease: ischemic heart disease. Bogden J.D. Klevay L.M. eds. Clinical Nutrition of the Essential Trace Elements and Minerals: The Guide for Health Professionals 2000 The Humana Press Inc. Totowa, NJ.
34. Klevay L. M., Canfield W. K., Gallagher S. K., Henriksen L. K., Lukaski H. C., Bolonchuk W., Johnson L. K., Milne D. B., Sandstead H. H. Decreased glucose tolerance in two men during experimental copper depletion. Nutr. Rep. Int. 1986;33:371-382
35. Klevay L. M., Inman L., Johnson L. K., Lawler M., Mahalko J. R., Milne D. B., Lukaski H. C., Bolonchuk W., Sandstead H. H. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism 1984;33:1112-1118[Medline]
36. Klevay L. M., Milne D. B., Wallwork J. C. Comparison of some indices of copper deficiency in growing rats. Nutr. Rep. Int. 1985;31:963-971
37. Klevay L. M., Pond W. G., Medeiros D. M. Decreased high density lipoprotein cholesterol and apoprotein A-I in plasma and ultrastructural pathology in cardiac muscle of young pigs fed a diet high in zinc. Nutr. Res. 1994;14:1227-1239
38. Klevay L. M., Viestenz K. E. Abnormal electrocardiograms in rats deficient in copper. Am. J. Physiol. 1981;240:H185-H189[Medline]
39. Kopp S. J., Klevay L. M., Feliksik J. M. Physiological and metabolic characterization of a cardiomyopathy induced by chronic copper deficiency. Am. J. Physiol. 1983;245:H855-H866
40. Lukaski H. C., Klevay L. M., Milne D. B. Effects of dietary copper on human autonomic cardiovascular function. Eur. J. Appl. Physiol. 1988;58:74-80
41. McCord J. M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 1985;312:159-163[Abstract]
42. Medeiros D. M. Hypertension in the Wistar-Kyoto rat as a result of post-weaning copper restriction. Nutr. Res. 1987;7:231-235
43. Mendis S., Sobotka P. A., Leja F. L., Euler D. E. Breath pentane and plasma lipid peroxides in ischemic heart disease. Free Radic. Biol. Med. 1995;19:679-684[Medline]
44. Mielcarz G. W., Howard A. N., Williams N. R., Kinsman G. D., Moriguchi E., Moriguchi Y., Mizushima S., Yamori Y. Copper and zinc status as a risk factor for ischemic heart disease: a comparison between Japanese in Brazil and Okinawa. J. Trace Elem. Exp. Med. 1997;10:29-35
45. Owen C. A., Jr. Biochemical aspects of copper 1st ed. 1982:11 and 78 Noyes Publications Park Ridge, NJ.
46. Penttilä O., Neuvonen P. J., Himberg J. J., Siltanen P., Järvinen A., Merikallio E. Auricular myocardial cation concentrations in certain heart diseases in man. Trace Elem. Med. 1986;3:47-51
47. Prohaska J. R. Biochemical changes in copper deficiency. J. Nutr. Biochem. 1990;1:452-461
48. Radhakrishnamurthy B., Ruiz H., Dalferes E. R., Jr, Klevay L. M., Berenson G. S. Composition of proteoglycans in the aortas of copper-deficient rats. Proc. Soc. Exp. Biol. Med. 1989;190:98-104[Medline]
49.
Reiser S., Smith J. C., Jr, Mertz W., Holbrook J. T., Scholfield D. J., Powell A. S., Canfield W. K., Canary J. J. Indices of copper status in humans consuming a typical American diet containing either fructose or starch. Am. J. Clin. Nutr. 1985;42:242-251
50. Russo C., Olivieri O., Girelli D., Faccini G., Zenari M. L., Lombardi S., Corrocher R. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J. Hypertens. 1998;16:1267-1271[Medline]
51. Saari J. T. Dietary copper deficiency and endothelium-dependent relaxation of rat aorta. Proc. Soc. Exp. Biol. Med. 1992;200:19-24[Medline]
52. Saari J. T., Reeves P. G., Noordewier B., Hall C. B., Lukaski H. C. Cardiovascular but not renal effects of copper deficiency are inhibited by dimethyl sulfoxide. Nutr. Res. 1990;10:467-477
53. Sakuma N., Hibino T., Sato T., Ohte N., Akita S., Tamai N., Sasai K., Yoshimata T., Fujinami T. Levels of thiobarbituric acid-reactive substance in plasma from coronary artery disease patients. Clin. Biochem. 1997;30:505-507[Medline]
54.
Schultze M. O. The effect of deficiencies in copper and iron on the cytochrome oxidase of rat tissues. J. Biol. Chem. 1939;129:729-737
55. Shields G. S., Coulson W. F., Kimball D. A., Cartwright G. E., Winthrobe M. Studies on copper metabolism XXXII. Cardiovascular lesions in copper deficient swine. Am. J. Pathol. 1962;41:603-621
56. Southorn P. A., Powis G. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin. Proc. 1988;63:381-389[Medline]
57. Teague H. S., Carpenter L. E. The demonstration of a copper deficiency in young growing pigs. J. Nutr. 1951;43:389-399[Medline]
58.
Tilson M. D. Decreased hepatic copper levels. A possible chemical marker for the pathogenesis of aortic aneurysms in man. Arch. Surg. 1982;117:1212-1213
59.
Viestenz K. E., Klevay L. M. A randomized trial of copper therapy in rats with electrocardiographic abnormalities due to copper deficiency. Am. J. Clin. Nutr. 1982;35:258-266
60.
Waddell J., Elvehjem C. A., Steenbock H., Hart E. B. Iron in nutrition. VI. Iron salts and iron-containning ash extracts in the correction of anemia. J. Biol. Chem. 1928;77:777-795
61. Waisman J., Cancilla P. A., Coulson W. F. Cardiovascular studies on copper-deficient swine. XIII. The effect of chronic copper deficiency on the cardiovascular system of miniature pigs. Lab. Invest. 1969;21:548-554[Medline]
62.
Wang X. L., Adachi T., Sim A. S., Wilcken D. E. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 1998;18:1915-1921
63. Wester P. O. Trace elements in human myocardial infarction determined by neutron activation analysis. Acta Med. Scand. 1965;178:765-788[Medline]
64. Zama N., Towns R. L. Cardiac copper, magnesium, and zinc in recent and old myocardial infarction. Biol. Trace Elem. Res. 1986;10:201-208
This article has been cited by other articles:
![]() |
S. A. Lowndes, A. Adams, A. Timms, N. Fisher, J. Smythe, S. M. Watt, S. Joel, F. Donate, C. Hayward, S. Reich, et al. Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors Clin. Cancer Res., November 15, 2008; 14(22): 7526 - 7534. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||